Upcoming Live Courses

Title Credit Dates
CAR T-Cell Therapy: Recent Advances and Future Considerations
  • 1.25 ACPE contact hours credits
  • 1.25 AMA PRA Category 1 Credit™ credits
  • 1.25 ANCC contact hours credits
  • 1.25 Participation credits
11/15/2018 - 2:00pm to 3:15pm
NCCN Pharmacy Updates: New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm
  • 1.00 ACPE contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC contact hours credit
  • 1.00 Participation credit
11/27/2018 - 12:30pm to 1:30pm
NCCN 2018 Congress Webinar Series: Acute Leukemia - Monitoring Minimal Residual Disease in Leukemia and Impact on Treatment
  • 1.00 ABIM MOC credit
  • 1.00 ACPE contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC contact hours credit
  • 1.00 Participation credit
11/29/2018 - 1:00pm to 2:00pm
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Melanoma
  • 1.00 ACPE contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC contact hours credit
  • 1.00 CCM clock hours credit
  • 1.00 Participation credit
12/07/2018 - 10:30am to 11:30am
NCCN Pharmacy Updates: Role of Biosimilar Agents in Myeloid Growth Factor Therapy
  • 1.00 ACPE contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC contact hours credit
  • 1.00 Participation credit
12/12/2018 - 1:30pm to 2:30pm

Pages

Featured Courses

Title Credit Type
Biosimilars in the Evolving Cancer Care Landscape: Experts Address Current Questions, Controversies, and Impact on Clinical Practice
  • 1.00 ACPE contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 0.88 ANCC contact hours credits
  • 1.00 Participation credit
Enduring
Emerging Systemic Therapy Options in Advanced Hepatocellular Carcinoma
  • 0.75 ACPE contact hours credits
  • 0.75 AMA PRA Category 1 Credit™ credits
  • 0.82 ANCC contact hours credits
  • 0.75 Participation credits
Enduring
Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy
  • 1.00 ACPE contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 0.88 ANCC contact hours credits
  • 1.00 Participation credit
Enduring
Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma
  • 0.75 ACPE contact hours credits
  • 0.75 AMA PRA Category 1 Credit™ credits
  • 0.72 ANCC contact hours credits
  • 0.75 Participation credits
Enduring
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Improving Quality of Care for Lesbian, Gay, Bisexual, and Transgender (LGBT...
  • 0.85 ANCC contact hours credits
  • 0.85 Participation credits
Enduring

Pages

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.